Mark William Lowdell insider trades
Open-market stock purchases and sales by Mark William Lowdell, Chief Scientific Officer at Inmune Bio, Inc, from SEC Form 4 filings since Sep 11, 2019.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -75%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 2, 2026 | INMB Inmune Bio, Inc | Bought (not open market) | $10.1K |
| Jul 2, 2026 | INMB Inmune Bio, Inc | Bought (not open market) | $901 |
| Dec 1, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | — |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $992K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $150K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $3.1M |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $600K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $704K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $270K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $824K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $156K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $707K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $210K |
Companies traded
- INMB Inmune Bio, Inc: 2 buys, 5 sales, last Jul 2, 2026
Get free alerts when Mark William Lowdell files a new trade →